{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:28:02Z","timestamp":1790116082397,"version":"4.0.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study investigated the prevalence and clinical correlates of renal phenotypes in two cohorts of type 2 diabetes (T2D) patients, assessed temporal trends, and evaluated associations with treatment regimens. These figures were compared to those previously recorded in a similar, real world cohort 15 years earlier in Italy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data from 378\u2009914 T2D patients attending the AMD network in 2023 in Italy were retrieved and compared to a similar cohort of prevalent patients in 2009. Renal phenotypes were classified as isolated albuminuria, isolated reduced eGFR (&amp;lt;60\u00a0ml\/min\/1.73 m\u00b2), or both. Multivariate logistic regression identified factors associated with these phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the 2023 study cohort, 51.3% of patients showed preserved renal function, 17.9% had isolated low eGFR, 17.4% had isolated albuminuria, and 13.3% exhibited both conditions. Female gender was independently associated with isolated low eGFR (OR\u00a0=\u00a01.28), whereas male gender was linked to albuminuria. Age was significantly related to both renal abnormalities, while longer diabetes duration increased the likelihood of low eGFR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared with the 2009 cohort, the prevalence of CKD in T2D remains stable in 2023, with albuminuric phenotypes decreasing and isolated low eGFR phenotypes increasing. These trends may reflect the aging population and evolving treatment practices, including a growing use of nephroprotective agents such as RAS inhibitors, SGLT2 inhibitors, and GLP-1 receptor agonists as well as better control of blood pressure. Longitudinal ad hoc studies are needed to address changing clinical scenarios.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfag069","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T12:49:51Z","timestamp":1772282991000},"source":"Crossref","is-referenced-by-count":2,"title":["Evolving kidney disease phenotypes in type 2 diabetes: declining albuminuria and increasing isolated low eGFR"],"prefix":"10.1093","volume":"19","author":[{"given":"Salvatore A","family":"De\u00a0Cosmo","sequence":"first","affiliation":[{"name":"Departement of Clinical Sciences, Unit of Internal Medicine, IRCCS \u201cCasa Sollievo Della Sofferenza\u201d , San Giovanni Rotondo, FG ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Russo","sequence":"additional","affiliation":[{"name":"University of Messina Department of Clinical and Experimental Medicine, , Messina ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Nicolucci","sequence":"additional","affiliation":[{"name":"CORESEARCH - Center for Outcomes Research and Clinical Epidemiology , Pescara ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Rossi","sequence":"additional","affiliation":[{"name":"CORESEARCH - Center for Outcomes Research and Clinical Epidemiology , Pescara ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusi","family":"Graziano","sequence":"additional","affiliation":[{"name":"CORESEARCH - Center for Outcomes Research and Clinical Epidemiology , Pescara ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Fioretto","sequence":"additional","affiliation":[{"name":"University of Padua, Unit of Medical Clinic 3 Department of Medicine, , Padua ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9139-7159","authenticated-orcid":false,"given":"Dario","family":"Tuccinardi","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Campus Bio-Medico , Via Alvaro del Portillo, Roma ,","place":["Italy"]},{"name":"Universit\u00e0 Campus Bio-Medico di Roma Research Unit of Endocrinology and Diabetology, Department of Medicine and Surgery, , Via Alvaro del Portillo, Roma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4219-7043","authenticated-orcid":false,"given":"Francesca","family":"Viazzi","sequence":"additional","affiliation":[{"name":"University of Genova Department of Internal Medicine and Medical Specialties (DIMI), , Genova ,","place":["Italy"]},{"name":"IRCCS AOM , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Sartore","sequence":"additional","affiliation":[{"name":"University of Padova Department of Medicine-DIMED, , Padova ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Muscar\u00e0","sequence":"additional","affiliation":[{"name":"University of Messina Department of Clinical and Experimental Medicine, , Messina ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cuttone","sequence":"additional","affiliation":[{"name":"University of Messina Department of Clinical and Experimental Medicine, , Messina ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6788-3032","authenticated-orcid":false,"given":"Pamela","family":"Piscitelli","sequence":"additional","affiliation":[{"name":"Departement of Clinical Sciences, Unit of Internal Medicine, IRCCS \u201cCasa Sollievo Della Sofferenza\u201d , San Giovanni Rotondo, FG ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Candido","sequence":"additional","affiliation":[{"name":"Azienda Sanitaria Universitaria Giuliano Isontina , Trieste ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Di\u00a0Cianni","sequence":"additional","affiliation":[{"name":"Diabetes and Metabolic Diseases Unit, Health Local Unit Nord-West Tuscany, Livorno Hospital , Pad. 4, Viale Alfieri 36, Livorno (LI) ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pontremoli","sequence":"additional","affiliation":[{"name":"University of Genova Department of Internal Medicine and Medical Specialties (DIMI), , Genova ,","place":["Italy"]},{"name":"IRCCS AOM , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"2026042108115760800_bib1","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","article-title":"A single number for advocacy and communication-worldwide more than 850 million individuals have kidney disease","volume":"96","author":"Jager","year":"2019","journal-title":"Kidney Int"},{"key":"2026042108115760800_bib2","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"key":"2026042108115760800_bib3","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/sj.ki.5000377","article-title":"Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective","volume":"69","author":"Parving","year":"2006","journal-title":"Kidney Int"},{"key":"2026042108115760800_bib4","volume-title":"USRDS Annual Data Report: Epidemiology of kidney disease in the United States","author":"United States Renal Data System","year":"2019"},{"key":"2026042108115760800_bib5","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1371\/journal.pmed.0050207","article-title":"The relationship between proteinuria and coronary risk: a systematic review and meta-analysis","volume":"5","author":"Perkovic","year":"2008","journal-title":"PLoS Med"},{"key":"2026042108115760800_bib6","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1681\/ASN.2008121270","article-title":"Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes","volume":"20","author":"Ninomiya","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2026042108115760800_bib7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes","volume":"24","author":"Afkarian","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2026042108115760800_bib8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1056\/NEJM198402093100605","article-title":"Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes","volume":"310","author":"Mogensen","year":"1984","journal-title":"N Engl J Med"},{"key":"2026042108115760800_bib9","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/archinte.160.8.1093","article-title":"The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus","volume":"160","author":"Valmadrid","year":"2000","journal-title":"Arch Intern Med"},{"key":"2026042108115760800_bib10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"HOPE Study Investigators: albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"key":"2026042108115760800_bib11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/kidneydial2030038","article-title":"The epidemiology of diabetic kidney disease","volume":"2","author":"Hoogeveen","year":"2022","journal-title":"Kidney Dialysis"},{"key":"2026042108115760800_bib12","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1001\/jama.2015.9536","article-title":"Diabetes: advances in diagnosis and treatment","volume":"314","author":"Nathan","year":"2015","journal-title":"JAMA"},{"key":"2026042108115760800_bib13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.pcd.2013.04.010","article-title":"Trends in cardiovascular risk factors among people with diabetes in a population based study, health survey for England 1994-2009","volume":"7","author":"Samaranayaka","year":"2013","journal-title":"Primary Care Diabetes"},{"key":"2026042108115760800_bib14","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990-2010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"2026042108115760800_bib15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","article-title":"Global trends in diabetes complications: a review of current evidence","volume":"62","author":"Harding","year":"2019","journal-title":"Diabetologia"},{"key":"2026042108115760800_bib16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/ndt\/gft506","article-title":"Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes","volume":"29","author":"De\u00a0Cosmo","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2026042108115760800_bib17","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1097\/HJH.0b013e3283495cd6","article-title":"Clinical significance of nonalbuminuric renal impairment in type 2 diabetes","volume":"29","author":"Penno","year":"2011","journal-title":"J Hypertens"},{"key":"2026042108115760800_bib18","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.2337\/dc08-0469","article-title":"Baseline quality-of-care data from a quality-improvement program implemented by a network of diabetes outpatient clinics","volume":"31","author":"Associazione Medici Diabetologi Annals Study Group.","year":"2008","journal-title":"Diabetes Care"},{"key":"2026042108115760800_bib19","doi-asserted-by":"publisher","first-page":"110672","DOI":"10.1016\/j.diabres.2023.110672","article-title":"The AMD ANNALS: a continuous initiative for the improvement of type 2 diabetes care","volume":"199","author":"Russo","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"2026042108115760800_bib20","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/j.1464-5491.2010.03055.x","article-title":"Four year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics: the AMD-Annals initiative","volume":"27","author":"Nicolucci","year":"2010","journal-title":"Diabet Med"},{"key":"2026042108115760800_bib21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026042108115760800_bib22","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"2026042108115760800_bib23","article-title":"2024 Annual Data Report. Chronic Kidney Disease: chapter 1","author":"USRDS","journal-title":"CKD in the general population"},{"key":"2026042108115760800_bib24","first-page":"e069770","article-title":"Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006\u20132019: a registry-based cohort study","volume":"13","author":"Leosdottir","year":"2023","journal-title":"Brit Med J Open"},{"key":"2026042108115760800_bib25","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMsa2032271","article-title":"Trends in diabetes treatment and control in U. S. adults, 1999\u20132018","volume":"384","author":"Fang","year":"2021","journal-title":"N Engl J Med"},{"key":"2026042108115760800_bib26","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.2337\/dc21-S010","article-title":"10. Cardiovascular disease and risk management: standards of medical care in diabetes-2021","volume":"44","author":"American Diabetes Association","year":"2021","journal-title":"Diabetes Care"},{"key":"2026042108115760800_bib27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"key":"2026042108115760800_bib28","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jama.2016.10924","article-title":"Clinical manifestations of kidney disease among us adults with diabetes, 1988-2014","volume":"316","author":"Afkarian","year":"2016","journal-title":"JAMA"},{"key":"2026042108115760800_bib29","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/ndt\/gfq526","article-title":"The use of eGFR and ACR to predict decline in renal function in people with diabetes","volume":"26","author":"Hoefield\u2008RA","year":"2011","journal-title":"Nephrol Dialysis Transplant"},{"key":"2026042108115760800_bib30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1053\/j.ajkd.2018.02.364","article-title":"Risk of progression of nonalbuminuric CKD to end-stage kidney disease in people with diabetes: the CRIC (Chronic Renal Insufficiency Cohort) study","volume":"72","author":"Koye","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2026042108115760800_bib31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2337\/dc17-1954","article-title":"Increasing mortality in adults with diabetes and low estimated glomerular filtration rate in the absence of albuminuria","volume":"41","author":"Kramer","year":"2018","journal-title":"Diabetes Care"},{"key":"2026042108115760800_bib32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00125-021-05590-5","article-title":"Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency","volume":"65","author":"Yamamoto","year":"2022","journal-title":"Diabetologia"},{"key":"2026042108115760800_bib33","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2337\/dc19-1438","article-title":"Risk of rapid kidney function decline, all-cause mortality, and major cardiovascular events in nonalbuminuric chronic kidney disease in type 2 diabetes","volume":"43","author":"Buyadaa","year":"2020","journal-title":"Diabetes Care"},{"key":"2026042108115760800_bib34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11892-002-0123-1","article-title":"The relationship between glucose control and the development and progression of diabetic nephropathy","volume":"2","author":"Phillips","year":"2002","journal-title":"Curr Diab Rep"},{"key":"2026042108115760800_bib35","doi-asserted-by":"publisher","first-page":"e4007","DOI":"10.1097\/MD.0000000000004007","article-title":"The AMD-Annals Study Group. Predictors of chronic kidney disease in type 2 diabetes: a longitudinal study from the AMD Annals initiative","volume":"95","author":"De\u00a0Cosmo","year":"2016","journal-title":"Medicine"},{"key":"2026042108115760800_bib36","first-page":"CD010137","article-title":"Glucose targets for preventing diabetic kidney disease and its progression","volume":"6","author":"Ruospo","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026042108115760800_bib37","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","article-title":"Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials","volume":"5","author":"Zoungas","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026042108115760800_bib38","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.2147\/DMSO.S436046","article-title":"Obesity patterns, metabolic abnormality, and diabetic kidney disease in patients with type 2 diabetes","volume":"16","author":"Zhang","year":"2023","journal-title":"Diabetes Metabol Syndr Obesity"},{"key":"2026042108115760800_bib39","doi-asserted-by":"publisher","first-page":"e006745","DOI":"10.1161\/JAHA.117.006745","article-title":"Resistant hypertension, time-updated blood pressure values and renal outcome in type 2 diabetes mellitus","volume":"6","author":"Viazzi","year":"2017","journal-title":"JAHA"},{"key":"2026042108115760800_bib40","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jdiacomp.2014.08.002","article-title":"Systolic blood pressure as a predictor of incident albuminuria and rapid renal function decline in type 2 diabetic patients","volume":"28","author":"Sheen","year":"2014","journal-title":"J Diabetes Complications"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag069\/67198967\/sfag069.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/4\/sfag069\/68113903\/sfag069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/4\/sfag069\/68113903\/sfag069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:12:07Z","timestamp":1776773527000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag069\/8503489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag069","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,2]]},"article-number":"sfag069"}}